Kumar Selvarajoo, PhD

Biography

Kumar is a Chief Scientist of Zhejiang Key Laboratory for Antitumor Drug Discovery using Computational Biology and AI. He is a native Singaporean who previously held Senior Principal Investigator/Faculty roles at ASTAR Bioinformatics , the Yong Loo Lin School of Medicine, National University of Singapore, and the School of Biological Sciences, Nanyang Technological University. Prior, he was an Associate Professor in Systems Biology at the Institute for Advanced Biosciences, Keio University, Japan. He serves the editorial board of BMC Biology (Nature Publishing Group), Genomics (Elsevier),  Frontiers in Immunology, and Biotechnology Notes (KeAi Publishing). He has lead teams in Computational Biology, Systems Biology, Bioinformatics and Statistical Genetics. In particular, he has used original ideas, utilizing fundamental statistical laws, to investigate multi-dimensional datasets, deterministic and stochastic modelling of complex signaling and metabolic networks. He has authored over 100 scientific articles, largely as corresponding author, which includes a single-authored book on Immuno Systems Biology (Springer), and has obtained several research grants, and an international grant reviewer. He has also presented invited/keynote talks at numerous international conferences. In 2013, 2015 and 2018, he founded and chaired the Symposium on Complex Biodynamics and Networks (cBio).

Research Interests

Computational biology, systems biology, bioinformatics, statistical and machine learning omics